
Tetrahedron p. 6259 - 6270 (1994)
Update date:2022-08-02
Topics:
Katoh, Tadashi
Kirihara, Masayuki
Yoshino, Toshiharu
Tamura, Osamu
Ikeuchi, Fumiaki
Nakatani, Kazuhiko
Matsuda, Fuyuhiko
Yamada, Kaoru
Gomi, Katsushige
Ashizawa, Tadashi
Terashima, Shiro
The antitumor activity of various structural types of quinocarcin congeners which had been previously prepared in the course of our synthetic studies or were originally synthesized by employing novel synthetic schemes, was primarily evaluated by in vitro cytotoxicity assay against P388 murine leukemia cells. Several compounds exhibiting prominent cytotoxicity were selected, and further subjected to in vitro cytotoxicity assay against HeLa S3 cells and to in vivo antitumor activity assay against P388 murine leukemia. These studies obviously disclosed novel aspects of the structure-activity relationships of quinocarcin congeners.
View MoreBeijing Zhongshuo Pharmaceutical T & D Co.,Ltd
Contact:0086-10-64430626
Address:ea No 16, HEPINGLI,DONGCHENG DISTRICT,BEIJING,P.R.CHINA.
Dalian Join King Biochemical Tech. Co., Ltd.
Contact:0411 39216206
Address:814 First State Blvd
CGeneTech (Suzhou, China) Co., Ltd.
Contact:+86-512-62956962
Address:Room 101,Bld C11,218 Xinghu Rd.,Suzhou industrial Park
website:http://www.herbpurify.com
Contact:0086-028-85249238
Address:Room709-C1,Incubator Building, Tianfu Life Science Park No.88,Keyuan Road,Gaoxin district,Chengdu City,Sichuan Prov,China
Shenzhen HwaGen Pharmaceutical Co., Ltd
website:http://www.rafflespt.com
Contact:+86-752-5538396
Address:Guangdong Huizhou China
Doi:10.1016/0008-6215(94)84212-4
(1994)Doi:10.1021/ja00058a021
(1993)Doi:10.1135/cccc19940957
(1994)Doi:10.1016/0008-6215(94)90022-1
(1994)Doi:10.1134/S107036321801005X
()Doi:10.1021/bc5000115
(2014)